サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786465

薬剤溶出バルーンカテーテルの世界市場

Drug-Eluting Balloon Catheters

出版日
ページ情報
英文 279 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
薬剤溶出バルーンカテーテルの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 279 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

薬剤溶出バルーンカテーテルの世界市場は2030年までに9億3,590万米ドルに達する見込み

2024年に6億1,880万米ドルと推定される薬剤溶出バルーンカテーテルの世界市場は、2024年から2030年にかけてCAGR 7.1%で成長し、2030年には9億3,590万米ドルに達すると予測されます。本レポートで分析されているセグメントの一つであるポリウレタンは、CAGR6.1％を記録し、分析期間終了時には5億3,270万米ドルに達すると予測されています。ナイロンセグメントの成長率は、分析期間中CAGR 8.1％と推定されます。

米国市場は1億6,860万米ドルと推定、中国はCAGR11.0%で成長予測

米国の薬剤溶出バルーンカテーテル市場は、2024年に1億6,860万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 11.0%で推移し、2030年には1億9,430万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と6.8%と予測されています。欧州では、ドイツがCAGR 4.7%で成長すると予測されています。

世界の「薬剤溶出バルーンカテーテル」市場- 主要動向と促進要因のまとめ

薬剤溶出バルーンカテーテルが血管インターベンションに選ばれる理由とは？

心血管疾患（CVDs）や末梢動脈疾患（PADs）の増加により、従来のステントに代わる低侵襲で効果の高い薬剤溶出性バルーン（DEB）カテーテルの需要が大幅に高まっています。これらのカテーテルは、パクリタキセルやシロリムスなどの抗増殖薬を罹患動脈に直接送達し、再狭窄を減少させ、再手術の必要性を最小限にします。永久的なインプラントを残す薬剤溶出ステント（DES）とは異なり、DEBは一過性でありながら効果的な治療ソリューションを提供し、晩期血栓症のような長期的合併症を起こすことなく血管の開存性を確保します。このため、DEBは出血リスクの高い患者や細小血管疾患、あるいはインターベンションを繰り返す患者にとって特に有益です。加えて、特に高齢化社会における低侵襲治療への嗜好の高まりが、冠動脈、末梢、動静脈瘻（AVF）治療におけるDEBカテーテルの採用拡大を後押ししています。

薬剤溶出バルーンカテーテルの有効性を高める技術革新とは？

ポリマーを含まないドラッグコーティング、薬剤保持時間の延長戦略、標的薬物送達メカニズムにおけるブレークスルーが、DEB技術の改善を促進しています。次世代の親水性キャリア、ナノベースの薬剤製剤、生体吸収性材料は、動脈壁への薬剤の接着性を著しく高め、持続的な治療効果を保証しています。バルーンの設計とカテーテルの柔軟性の進歩も、薬物送達の精度と安全性を向上させ、手技のリスクを最小限に抑え、治療成績を最適化しています。さらに、血管内超音波（IVUS）や光干渉断層計（OCT）などのリアルタイム画像技術がDEBシステムに統合され、可視化と留置精度の向上が可能になりつつあります。FDAや欧州医薬品庁（EMA）などの規制機関がより多くの適応症に特化したDEBを承認するにつれ、市場では糖尿病性血管合併症、膝下インターベンション、透析アクセス維持における有効性を評価する臨床試験が急増しています。

規制上の義務や市場動向はどのようにDEBの採用を後押ししているのか？

複数の血管適応症でDEBに対する規制当局の承認が増加していることが、DEBの世界の普及を加速させています。欧州では、DEBはステント内再狭窄の第一選択治療としてすでに広く受け入れられており、米国やアジア太平洋地域の規制当局も冠動脈、末梢、さらには神経血管への適応を拡大しつつあります。病院や外来手術センターは、費用対効果や入院期間の短縮を理由にカテーテルを用いた治療へとシフトしており、需要をさらに促進しています。さらに、バリュー・ベースのヘルスケアと外来血管形成術を推進する政府のイニシアチブが、DEBの利用を強力に後押ししています。DEBと生体吸収性スキャフォールドを組み合わせたハイブリッド手技が重視されるようになっていることも、長期的な血管治癒の結果をより良いものにする主要な市場動向です。

市場成長の主な促進要因は？

ドラッグ溶出バルーンカテーテル市場の成長は、心血管疾患や末梢動脈疾患の負担の増加、ドラッグデリバリーナノテクノロジーの進歩、低侵襲血管内治療の採用率の上昇によってもたらされます。DEBの用途が冠動脈インターベンション以外にも拡大し、特に糖尿病性足潰瘍、重症虚血肢、血液透析アクセス不全の治療が新たな市場機会を生み出しています。さらに、ヘルスケア支出の増加、インターベンショナル・カーディオロジーへの投資の増加、外来血管形成センターへのシフトが市場拡大を支えています。継続的な技術の進歩と継続的な臨床検証により、DEBカテーテルは次世代血管ケアに不可欠な要素になりつつあります。

セグメント

素材（ポリウレタン、ナイロン、その他）;エンドユース（病院＆クリニック、外来手術センター、カテーテル検査室）

調査対象企業の例

  • Balton Sp z o.o.
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U
  • JIANGSU CHANGMEI MEDTECH CO., LTD

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30609

Global Drug-Eluting Balloon Catheters Market to Reach US$935.9 Million by 2030

The global market for Drug-Eluting Balloon Catheters estimated at US$618.8 Million in the year 2024, is expected to reach US$935.9 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Polyurethane, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$532.7 Million by the end of the analysis period. Growth in the Nylon segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$168.6 Million While China is Forecast to Grow at 11.0% CAGR

The Drug-Eluting Balloon Catheters market in the U.S. is estimated at US$168.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$194.3 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global "Drug-Eluting Balloon Catheters" Market - Key Trends & Drivers Summarized

Why Are Drug-Eluting Balloon Catheters a Preferred Choice for Vascular Interventions?

The rise in cardiovascular diseases (CVDs) and peripheral artery diseases (PADs) has significantly increased the demand for drug-eluting balloon (DEB) catheters, which offer a less invasive and highly effective alternative to traditional stents. These catheters deliver antiproliferative drugs, such as paclitaxel and sirolimus, directly to the affected arteries, reducing restenosis and minimizing the need for repeat procedures. Unlike drug-eluting stents (DES), which leave behind a permanent implant, DEBs provide a transient yet effective therapeutic solution, ensuring vessel patency without long-term complications like late thrombosis. This makes them particularly beneficial for patients with high risks of bleeding, small vessel disease, or those undergoing repeat interventions. Additionally, the growing preference for minimally invasive procedures, especially among aging populations, has driven the increased adoption of DEB catheters in coronary, peripheral, and arteriovenous fistula (AVF) treatments.

What Innovations Are Enhancing the Effectiveness of Drug-Eluting Balloon Catheters?

Breakthroughs in polymer-free drug coatings, prolonged drug retention strategies, and targeted drug delivery mechanisms are driving improvements in DEB technology. Next-generation hydrophilic carriers, nano-based drug formulations, and bioabsorbable materials have significantly enhanced drug adhesion to arterial walls, ensuring sustained therapeutic effects. Advancements in balloon design and catheter flexibility have also improved the precision and safety of drug delivery, minimizing procedural risks and optimizing outcomes. Furthermore, real-time imaging technologies, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are now being integrated into DEB systems, allowing for enhanced visualization and placement accuracy. As regulatory bodies such as the FDA and European Medicines Agency (EMA) approve more indication-specific DEBs, the market is witnessing a surge in clinical trials evaluating their efficacy in diabetic vascular complications, below-the-knee interventions, and dialysis access maintenance.

How Are Regulatory Mandates and Market Trends Driving Adoption?

The increasing regulatory approvals for DEBs across multiple vascular indications have accelerated their global adoption. In Europe, drug-eluting balloon catheters have already gained widespread acceptance as a first-line treatment for in-stent restenosis, while regulatory agencies in the U.S. and Asia-Pacific are expanding approvals for coronary, peripheral, and even neurovascular applications. Hospitals and ambulatory surgical centers are shifting towards catheter-based interventions due to their cost-effectiveness and shorter hospital stays, further fueling demand. Additionally, government initiatives promoting value-based healthcare and outpatient angioplasty procedures have provided a strong push toward DEB utilization. The growing emphasis on hybrid procedures that combine DEBs with bioresorbable scaffolds is also a key market trend, offering better long-term vascular healing outcomes.

What Are the Primary Market Growth Drivers?

The growth in the Drug-Eluting Balloon Catheter market is driven by the increasing burden of cardiovascular and peripheral artery diseases, advancements in drug delivery nanotechnology, and the rising adoption of minimally invasive endovascular procedures. The expansion of DEB applications beyond coronary interventions, particularly in treating diabetic foot ulcers, critical limb ischemia, and hemodialysis access failures, has created new market opportunities. Additionally, rising healthcare expenditures, increasing investments in interventional cardiology, and the shift toward outpatient angioplasty centers are supporting market expansion. With ongoing technological advancements and continuous clinical validation, DEB catheters are poised to become an indispensable component of next-generation vascular care.

SCOPE OF STUDY:

The report analyzes the Drug-Eluting Balloon Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Polyurethane, Nylon, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Catheterization Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Balton Sp z o.o.
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U
  • JIANGSU CHANGMEI MEDTECH CO., LTD

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Drug-Eluting Balloon Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Peripheral Artery Disease Spurs Demand for Drug-Eluting Balloon Catheters
    • Aging Population and Prevalence of Chronic Cardiovascular Conditions Strengthen Business Case for Drug-Eluting Therapies
    • Increasing Preference for Minimally Invasive Procedures Accelerates Adoption of Drug-Eluting Balloon Catheters
    • Clinical Success and Favorable Outcomes Propel Growth of Drug-Eluting Balloon Technologies
    • Shorter Recovery Times and Reduced Restenosis Risk Drive Demand in Outpatient and Day-Care Surgical Settings
    • Technological Innovations in Drug Coating and Delivery Systems Expand Addressable Market Opportunity
    • Surge in Endovascular Interventions Across Emerging Economies Throws the Spotlight on Drug-Eluting Balloons
    • Shift from Traditional Angioplasty to Drug-Eluting Devices Fuels Market Transformation
    • Integration of Biodegradable Materials in Balloon Catheters Drives Innovation-Led Growth
    • Favorable Reimbursement Policies in Developed Markets Sustain Growth Momentum
    • Expanding Pipeline of Clinical Trials and Regulatory Approvals Unlocks New Market Avenues
    • Expansion of Ambulatory Surgical Centers Across Urban and Semi-Urban Regions Generates New Demand Nodes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug-Eluting Balloon Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Nylon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Catheterization Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • FRANCE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION